Brain Pericytes plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Brain pericytes are specialized perivascular cells that ensheath the capillary walls of the cerebral microvasculature, forming a critical component of the neurovascular unit. These cells play essential roles in maintaining blood-brain barrier (BBB) integrity, regulating cerebral blood flow, controlling angiogenesis, and supporting neuronal survival. Pericytes are increasingly recognized as key players in neurodegenerative diseases, with pericyte loss identified as an early pathological feature in Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Understanding pericyte biology is crucial for developing therapeutic strategies targeting the neurovascular system in neurodegeneration.
¶ Location and Distribution
Brain pericytes are positioned on the abluminal (brain-facing) surface of cerebral capillaries, embedded within the basement membrane that surrounds endothelial cells. They are most abundant in the cerebral cortex and hippocampal regions, with varying densities across brain regions:
- Capillary pericytes: Cover 60-80% of capillary surfaces
- Pre-capillary arteriole pericytes: Pre-capillary sphincters
- Venular pericytes: Post-capillary venules
- Regional variation: Higher density in gray matter vs. white matter
Pericytes exhibit distinctive morphological features:
- Cell body: Small, elongated cell body (~10-15 μm)
- Processes: Long, branching cytoplasmic extensions
- Coverage: Each pericyte covers 50-100 μm of capillary length
- Pavement-like arrangement: Non-overlapping territories
- Membrane specializations: Peg-and-socket contacts with endothelial cells
- Mesh pericytes: Dense, overlapping processes in high-flow regions
- Transitional pericytes: Intermediate morphology
- Ensheathing pericytes: Single layer processes in lower-flow areas
- Solitary pericytes: Sparse, with limited coverage
Brain pericytes express several characteristic markers:
- NG2 (CSPG4): Chondroitin sulfate proteoglycan 4
- PDGFR-β: Platelet-derived growth factor receptor beta
- CD13: Aminopeptidase N
- RGS5: Regulator of G-protein signaling 5
- Desmin: Intermediate filament
- α-SMA: Alpha-smooth muscle actin (in some pericytes)
Pericytes communicate with endothelial cells to maintain BBB integrity:
- Claudin-5: Tight junction protein regulation
- Occludin: Tight junction assembly
- ZO-1: Scaffolding protein recruitment
- VE-cadherin: Endothelial junction maintenance
¶ Blood-Brain Barrier Maintenance
Pericytes are essential for BBB development and maintenance:
Developmental Role:
- Pericyte recruitment via PDGFB/PDGFR-β signaling
- Induction of tight junction formation
- Polarization of endothelial transport
- BBB-specific gene expression
Adult Maintenance:
- Continuous tight junction support
- Basement membrane organization
- Transport regulation
- Response to BBB injury
Pericytes are the primary regulators of capillary blood flow:
Contractile Properties:
- Contain actin-myosin machinery
- Respond to vasoactive signals
- Capillary diameter control
- Pre-capillary sphincter function
Neurovascular Coupling:
- Respond to neuronal activity
- Mediate blood flow increases
- Coordinate arteriole and capillary responses
- Maintain functional hyperemia
¶ Angiogenesis and Vascular Development
Pericytes participate in blood vessel formation:
- Vessel sprouting: Guide endothelial tip cells
- Vessel stabilization: Prevent regression
- Perivascular coverage: Maintain vessel integrity
- Quiescence: Prevent abnormal angiogenesis
Pericytes modulate immune responses in the brain:
- TNF-α and IL-1β responses: Inflammatory signaling
- Leukocyte trafficking: Regulate immune cell entry
- Cytokine production: Modulate neuroinflammation
- Barrier maintenance: During inflammation
Pericyte dysfunction is recognized as an early event in AD:
Pericyte Loss:
- Observed in post-mortem AD brain tissue
- Correlates with disease severity
- Precedes neuron loss
- Found in transgenic AD models
BBB Breakdown:
- Allows peripheral protein entry
- Compromises Aβ clearance
- Promotes neuroinflammation
- Disrupts neuronal homeostasis
Aβ Clearance:
- Pericytes internalize Aβ
- Receptor-mediated uptake (LRP1)
- Impaired in AD
- Contributes to plaque formation
Therapeutic Implications:
- PDGFR-β agonists: Promote pericyte survival
- Aβ clearance enhancement
- BBB stabilization strategies
Pericyte involvement in PD includes:
- Vascular dysfunction: Contributes to substantia nigra vulnerability
- Blood flow impairment: Altered cerebral hemodynamics
- BBB disruption: Observed in PD models
- α-synuclein interactions: Pericyte uptake of α-synuclein
Pericytes play complex roles in MS:
- Pericyte loss: Observed in active demyelinating lesions
- BBB repair: Pericyte recruitment for recovery
- Demyelination: Pericyte-mediated inflammation
- Therapeutic targeting: Promising avenue
¶ Stroke and Vascular Dementia
Pericytes are critical in cerebrovascular disease:
- Ischemic injury: Pericyte death after stroke
- Reperfusion damage: Contributes to injury
- Blood flow no-reflow: Capillary obstruction
- Angiogenesis: Important for recovery
Pericytes are damaged in diabetic brain:
- Advanced glycation end products: Toxic to pericytes
- Oxidative stress: Pericyte dysfunction
- BBB breakdown: Contributes to cognitive decline
Pharmacological Approaches:
- PDGFR-β agonists: Promote pericyte survival
- BMP4 treatment: Enhances pericyte coverage
- Angiopoietin-1: Stabilizes pericytes
- Antioxidants: Protect against oxidative stress
Pericytes as targets for CNS drug delivery:
- Receptor-mediated transcytosis: Target pericyte receptors
- Nanoparticle delivery: Pericyte-specific approaches
- Pericyte modulation: Temporarily increase BBB permeability
Pericyte-derived markers for neurodegeneration:
- sPDGFR-β: Soluble receptor in CSF/blood
- Pericyte-specific proteins: Diagnostic potential
- Imaging markers: MRI contrast agents
Emerging genetic approaches:
- PDGFR-β gene delivery: Promote pericyte function
- Angiogenic factors: VEGF, angiopoietin delivery
- Stem cell approaches: Pericyte progenitor therapy
- In vitro pericyte cultures: Primary brain pericyte isolation
- Transgenic mice: Pericyte-specific reporter lines
- Live imaging: Two-photon microscopy of pericytes
- Pericyte-deficient models: PDGFR-β conditional knockout
- Post-mortem analysis: Pericyte density and morphology
- iPSC-derived pericytes: Patient-specific models
- Imaging: Pericyte-specific MRI contrast
- Biomarker studies: CSF and blood markers
Brain Pericytes plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Brain Pericytes has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
Armulik A, et al. (2010) Pericytes regulate the blood-brain barrier. Nature 468:557-561
-
Bell RD, et al. (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and in spinal cord. Neuron 66:409-425
-
Sweeney MD, et al. (2016) Pericytes are critical for blood-brain barrier integrity and CNS homeostasis. Nat Rev Neurosci 17:29-40
-
Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12:723-738
-
Nikolakopoulou AM, et al. (2019) Pericyte loss leads to capillary regression and neurovascular unit disruption in Alzheimer's disease. Nat Neurosci 22:1495-1504
-
Montagne A, et al. (2015) Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85:296-302
-
Sagare AP, et al. (2013) Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat Commun 4:2932
-
Winkler EA, et al. (2011) Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol 121:241-251
-
Daneman R, et al. (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468:562-566
-
Tachibana M, et al. (2018) Pericyte dysfunction in neurodegenerative diseases. Neurochem Int 119:57-66